Goodwin Advises Calytrix Bio on Its Agreement To Be Acquired by Eli Lilly for up to $1.5 Billion
November 16, 2026
November 16, 2026
BOSTON, Massachusetts, Nov. 16 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:
* * *
Goodwin Advises Calytrix Bio on Its Agreement To Be Acquired by Eli Lilly for up to $1.5 Billion
*
The Life Sciences team advised Calytrix Bio, Inc. (Calytrix) on its definitive agreement to be acquired by Eli Lilly and Company (Lilly). Under the terms of the agreement, Lilly will acquire Calytrix, and Calytrix shareholders c . . .
* * *
Goodwin Advises Calytrix Bio on Its Agreement To Be Acquired by Eli Lilly for up to $1.5 Billion
*
The Life Sciences team advised Calytrix Bio, Inc. (Calytrix) on its definitive agreement to be acquired by Eli Lilly and Company (Lilly). Under the terms of the agreement, Lilly will acquire Calytrix, and Calytrix shareholders c . . .
